Research Associate

The Methodist Church in Britain; Bradford; Vor Ort; GBP 30.000 - 40.000; Vollzeit

Benefits dieser Stelle

25 days holiday

13 statutory and customary days

Family-friendly policies

Campus facilities

Employer contribution pension scheme

Salary sacrifice schemes

Campus nursery

Zusammenfassung

The University of Bradford invites applications for a Research Associate in the Institute of Cancer Therapeutics, within the Institute of Health and Social Care. The role tests hypoxia-selective cancer drugs using 2D and 3D cell models and supports drug development via LC-MS analysis.

Applicants should hold MSc or PhD or equivalent experience in related fields and have practical mammalian cell culture and molecular biology skills. Enhanced DBS checks apply.

Qualifikationen

• MSc or PhD, or equivalent research experience in cancer biology, pharmacology, molecular biology, biomedical sciences or related discipline.
• Practical laboratory-based research in cancer biology or related fields.
• Experience with cell culture and in vitro biological assays; data interpretation.

Aufgaben

• Evaluate novel hypoxia-selective therapeutics in 2D and 3D cancer models, alone and with chemotherapy and radiotherapy.
• Investigate mechanisms of action and therapeutic response using molecular biology, flow cytometry and gene editing.
• Support translational drug development through LC-MS studies of activation, stability and pharmacokinetics.
• Analyse data and disseminate findings.

Kenntnisse

Mammalian cell culture

Molecular biology techniques

Experimental design & data analysis

Team collaboration

Ausbildung

MSc or PhD in cancer biology or related

Tools

LC-MS analysis

Flow cytometry

Gene editing (CRISPR)

Jobbeschreibung

Research Associate post in the Institute of Cancer Therapeutics, part of the Institute of Health and Social Care at the University of Bradford. The work tests new hypoxia-selective cancer drugs in 2D and 3D cell models, probes how they act, and supports drug development through LC-MS analysis. The post is supported by a Wellcome Accelerator Award, and applications are encouraged from Black, Pakistani and Bangladeshi researchers. An enhanced DBS check applies, and a postgraduate degree or equivalent research experience is needed.

What the job involves

• Evaluate novel hypoxia-selective therapeutics in 2D and 3D cancer models, alone and with chemotherapy and radiotherapy
• Investigate mechanisms of action and therapeutic response using molecular and cellular biology, flow cytometry and gene editing
• Support translational drug development through LC-MS studies of activation, stability and pharmacokinetics
• Analyse data and disseminate findings

Qualifications

• MSc or PhD, or equivalent research experience, in cancer biology, pharmacology, molecular biology, biomedical sciences, pharmaceutical sciences or a related discipline

Experience

• Practical laboratory-based research in cancer biology, pharmacology, molecular biology, biomedical sciences or a related discipline
• Mammalian cell culture and in vitro biological assays
• Designing, conducting and analysing laboratory experiments and interpreting scientific data

Checks & eligibility

• Enhanced DBS check

What’s offered

• 25 days holiday plus 13 statutory and customary days
• Family-friendly policies
• Campus facilities
• Employer contribution pension scheme
• Salary sacrifice schemes
• Campus nursery